Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis

Autor: Kf, Laserson, Le, Thorpe, Leimane V, Weyer K, Cd, Mitnick, Riekstina V, Zarovska E, Ml, Rich, Hamish Fraser, Alarcón E, Jp, Cegielski, Grzemska M, Gupta R, Espinal M

Publikováno v: Europe PubMed Central

Globally it is estimated that 273000 new cases of multidrug-resistant tuberculosis (MDR-TB, resistance to isoniazid and rifampicin) occurred in 2000. To address MDR-TB management in the context of the DOTS strategy, the World Health Organization and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::6e0b5c68160707e8f3fb911e37cba3c6
https://pubmed.ncbi.nlm.nih.gov/15971391

Low body mass index as a predictor of sputum culture conversion and treatment outcomes among patients receiving treatment for multidrug-resistant tuberculosis in Lesotho.

Autor: Oyewusi L; Clinical department (MDRTB), Partners In Health, Maseru, Lesotho., Zeng C; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA., Seung KJ; Division of Global Health Equity, Brigham and Women's Hospital, Boston, MA, USA., Mpinda S; Clinical department (MDRTB), Partners In Health, Maseru, Lesotho., Kunda M; Clinical department (MDRTB), Partners In Health, Maseru, Lesotho., Mitnick CD; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA., Kanu M; Clinical department (MDRTB), Partners In Health, Maseru, Lesotho., Tamirat M; Clinical department (MDRTB), Partners In Health, Maseru, Lesotho., Makaka J; Clinical department (MDRTB), Partners In Health, Maseru, Lesotho., Mofolo M; Clinical department (MDRTB), Partners In Health, Maseru, Lesotho., Maime R; Clinical department (MDRTB), Partners In Health, Maseru, Lesotho., Maama L; National TB and Leprosy Programme, Lesotho Ministry of Health, Maseru, Lesotho., Senyo N; Clinical department (MDRTB), Partners In Health, Maseru, Lesotho., Oguntoyinbo B; Clinical department (MDRTB), Partners In Health, Maseru, Lesotho., Mayombo L; Clinical department (MDRTB), Partners In Health, Maseru, Lesotho., Franke MF; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA.

Publikováno v: Global health action [Glob Health Action] 2024 Dec 31; Vol. 17 (1), pp. 2305930. Date of Electronic Publication: 2024 Feb 02.

Accuracy of digital chest x-ray analysis with artificial intelligence software as a triage and screening tool in hospitalized patients being evaluated for tuberculosis in Lima, Peru.

Autor: Biewer AM; Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America., Tzelios C; Harvard Medical School, Boston, Massachusetts, United States of America., Tintaya K; Socios en Salud, Lima, Peru., Roman B; Socios en Salud, Lima, Peru., Hurwitz S; Harvard Medical School, Boston, Massachusetts, United States of America., Yuen CM; Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America., Mitnick CD; Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America., Nardell E; Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America., Lecca L; Socios en Salud, Lima, Peru., Tierney DB; Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.; Massachusetts Department of Public Health, Boston, Massachusetts, United States of America., Nathavitharana RR; Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America.

Publikováno v: PLOS global public health [PLOS Glob Public Health] 2024 Feb 07; Vol. 4 (2), pp. e0002031. Date of Electronic Publication: 2024 Feb 07 (Print Publication: 2024).

Pregnancy and Birth Outcomes in Patients With Multidrug-Resistant Tuberculosis Treated With Regimens That Include New and Repurposed Drugs.

Autor: Lotia Farrukh I; Interactive Research and Development Pakistan, Karachi, Pakistan., Lachenal N; Pharmacovigilance Unit, Médecins Sans Frontières, Geneva, Switzerland., Adenov MM; National Scientific Center of Phthisiopulmonology, Ministry of Health, Republic of Kazakhstan, Almaty, Kazakhstan., Ahmed S; Interactive Research and Development Pakistan, Karachi, Pakistan., Algozhin Y; Partners In Health, Almaty, Kazakhstan., Coutisson S; Pharmacovigilance Unit, Médecins Sans Frontières, Geneva, Switzerland., Garavito ES; Centro de Investigación de Enfermedades Neumológicas, Hospital Nacional Sergio Bernale, Lima, Peru., Hewison C; Medical Department, Médecins Sans Frontières, Paris, France., Holtzman D; Partners In Health, Maseru, Lesotho., Huerga H; Field Epidemiology Department, Epicentre, Paris, France., Janmohamed A; Interactive Research and Development Pakistan, Karachi, Pakistan., Khan PY; Interactive Research and Development Pakistan, Karachi, Pakistan.; London School of Hygiene & Tropical Medicine, London, United Kingdom., Jacques GL; Zanmi Lasante, Cange, Haiti., Lomtadze N; Surveillance and Strategic Planning, Ministry of Health, Tbilisi, Georgia., Melikyan N; Field Epidemiology Department, Epicentre, Yerevan, Armenia., Mitnick CD; Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Partners In Health, Boston, Massachusetts, USA., Mussabekova G; National Scientific Center of Phthisiopulmonology, Ministry of Health, Republic of Kazakhstan, Almaty, Kazakhstan., Osso E; Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA., Perea S; Socios En Salud Sucursal Peru, Lima, Peru., Putri FA; Interactive Research and Development Global, Jakarta, Indonesia., Rashidov M; Partners In Health, Almaty, Kazakhstan., Rich ML; Partners In Health, Boston, Massachusetts, USA.; Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts, USA., Sakhabutdinova Y; Partners In Health, Almaty, Kazakhstan., Seung KJ; Partners In Health, Boston, Massachusetts, USA.; Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts, USA., Stambekova A; Partners In Health, Almaty, Kazakhstan., Vásquez DV; Centro de Investigación, Hospital Nacional Hipólito Unanue, Lima, Peru., Franke MF; Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA., Khan U; Interactive Research and Development Pakistan, Karachi, Pakistan.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Jan 25; Vol. 78 (1), pp. 144-148.

Beyond goodwill and promises-urgent needs and opportunities to accelerate the fight against tuberculosis in Brazil.

Autor: Almeida CPB; Department of Global Health & Social Medicine, Harvard Medical School, 641 Huntington Ave, Room 3A05, Boston, MA 02115, USA.; Faculty of Public Health, Federal University of Sul e Sudeste do Pará, Folha 31, Quadra 07, Lote Especial, Marabá, PA 68507-590, Brazil., Trajman A; Department of Internal Medicine, Federal University of Rio de Janeiro, Rua Macedo Sobrinho 74/203, Humaitá, Rio de Janeiro, RJ, Brazil.; McGill TB International Centre, McGill University, Montreal, Quebec, Canada., Mitnick CD; Department of Global Health & Social Medicine, Harvard Medical School, 641 Huntington Ave, Room 3A05, Boston, MA 02115, USA., Kritski AL; Department of Internal Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil, Rua Professor Rodolpho Paulo Rocco, 255 - 6º Andar/Centro de Pesquisa em Tuberculose, Ilha do Fundão, Rio de Janeiro, RJ 21941913, Brazil., Santos-Filho ETD; Brazilian Tuberculosis Research Network, Av. Carlos Chagas Filho, 791 - Polo de Biotecnologia Cidade Universitária, Ilha do Fundão, Rio de Janeiro, RJ 21941904, Brazil.

Publikováno v: Lancet regional health. Americas [Lancet Reg Health Am] 2024 Jan 06; Vol. 30, pp. 100663. Date of Electronic Publication: 2024 Jan 06 (Print Publication: 2024).